Skip to main content
SpringerLink
Log in

Anti-Angiogenic Therapy in Ophthalmology

  • Book
  • © 2016

Overview

Editors:
  1. Andreas Stahl

    1. Eye Center at the Medical Center, University of Freiburg, Freiburg, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Explains why anti-angiogenic therapy is effective for various ocular diseases
  • Highlights the advantages and limitations of anti-angiogenic therapy
  • Written by established experts in their respective fields

Part of the book series: Essentials in Ophthalmology (ESSENTIALS)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (11 chapters)

  1. Front Matter

    Pages i-x
    Download chapter PDF

  2. Retinal Vascular Development

    • Jing Chen, Chi-Hsiu Liu, Przemyslaw Sapieha
    Pages 1-19

  3. Retinopathy of Prematurity

    • Andreas Stahl, Ann Hellström, Lois E. H. Smith
    Pages 21-29

  4. Anti-vascular Endothelial Growth Factor (VEGF) Treatment in Neovascular Age-Related Macular Degeneration: Outcomes and Outcome Predictors

    • Dujon Fuzzard, Robyn H. Guymer, Robert P. Finger
    Pages 31-65

  5. AREDS Supplementation and the Progression Towards Exudative AMD

    • David J. Valent, Emily Y. Chew
    Pages 67-77

  6. VEGF-Inhibition in Macular Telangiectasia Type 2

    • Peter Charbel Issa, Frank G. Holz
    Pages 79-87

  7. Diabetic Retinopathy

    • Focke Ziemssen, Hansjürgen T. Agostini
    Pages 89-130

  8. Retinal Vein Occlusion

    • Amelie Pielen, Bernd Junker, Nicolas Feltgen
    Pages 131-138

  9. Pharmacokinetics of Intravitreally Applied VEGF Inhibitors

    • Tim U. Krohne, Frank G. Holz, Carsten H. Meyer
    Pages 139-148

  10. Neovascular Glaucoma

    • Julia Lüke, Matthias Lüke, Salvatore Grisanti
    Pages 149-157

  11. Corneal Neovascular Diseases

    • Deniz Hos, Felix Bock, Björn Bachmann, Claus Cursiefen
    Pages 159-172

  12. Anti-Angiogenic Gene Therapy: Basic Science and Challenges for Translation into the Clinic

    • Clemens Lange, James Bainbridge
    Pages 173-188

  13. Back Matter

    Pages 189-193
    Download chapter PDF
Back to top

Keywords

About this book

This book provides a concise overview over the pathology of retinal angiogenic diseases and explains why anti-angiogenic therapy is effective in so many patients. The reader is guided through the various clinical indications for anti-angiogenic therapy and made aware of its merits as well as current challenges and limitations. It is explained how, since its introduction for the treatment of exudative age-related macular degeneration in 2006, anti-angiogenic therapy has revolutionized the way in which we treat a range of ocular diseases. All of the authors are established experts in their respective fields who share their extensive knowledge and clinical experience with the reader. This book is both a valuable introduction to anti-angiogenic therapy in ophthalmology and a day-to-day companion for all ophthalmologists seeing patients with some of the most prevalent retinal diseases.

Editors and Affiliations

  • Eye Center at the Medical Center, University of Freiburg, Freiburg, Germany

    Andreas Stahl

About the editor

Andreas Stahl, MD, FEBO, graduated in Medicine from the University of Freiburg, Germany, in 2005. He spent the years 2008-2010 as a Research Fellow in the Department of Ophthalmology, Harvard Medical School, Boston, thanks to a DFG fellowship grant. Since 2011, Dr. Stahl has been Head of the Angiogenesis Research Group at the University Eye Hospital Freiburg, investigating the underlying mechanisms of angioproliferative retinal diseases. Clinically, Dr. Stahl works as a retinal surgeon attending to patients with a broad variety of retinal disorders ranging from retinopathy of prematurity to ischemic retinopathies and age-related maculopathy. Dr. Stahl has been the recipient of numerous awards, including the Innovative Research Award from the German Ophthalmic Society. He is a reviewer for many journals and author of more than 40 articles in peer-reviewed journals as well as several book chapters.

Bibliographic Information

  • Book Title: Anti-Angiogenic Therapy in Ophthalmology

  • Editors: Andreas Stahl

  • Series Title: Essentials in Ophthalmology

  • DOI: https://doi.org/10.1007/978-3-319-24097-8

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer International Publishing Switzerland 2016

  • Hardcover ISBN: 978-3-319-24095-4Published: 25 May 2016

  • Softcover ISBN: 978-3-319-79580-5Published: 26 May 2018

  • eBook ISBN: 978-3-319-24097-8Published: 13 May 2016

  • Series ISSN: 1612-3212

  • Series E-ISSN: 2196-890X

  • Edition Number: 1

  • Number of Pages: X, 193

  • Number of Illustrations: 3 b/w illustrations, 23 illustrations in colour

  • Topics: Ophthalmology, Angiology

Publish with us

Policies and ethics

Back to top

Search

Navigation